42
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Clinical relevance of genotype–phenotype correlations beyond vascular events in a cohort study of 1500 Marfan syndrome patients with FBN1 pathogenic variants

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose

          Marfan syndrome (MFS) is a connective tissue disorder in which several systems are affected with great phenotypic variability. Although known to be associated with pathogenic variants in the FBN1 gene, few genotype–phenotype correlations have been found in proband studies only.

          Methods

          In 1,575 consecutive MFS probands and relatives from the most comprehensive database worldwide, we established survival curves and sought genotype–phenotype correlations.

          Results

          A risk chart could be established with clinical and genetic data. Premature termination codon variants were not only associated with a shorter life expectancy and a high lifelong risk of aortic event, but also with the highest risk of severe scoliosis and a lower risk for ectopia lentis (EL) surgery. In-frame variants could be subdivided according to their impact on the cysteine content of fibrillin-1 with a global higher severity for cysteine loss variants and the highest frequency of EL surgery for cysteine addition variants.

          Conclusion

          This study shows that FBN1 genotype–phenotype correlations exist for both aortic and extra-aortic features. It can be used for optimal risk stratification of patients with a great importance for genetic counseling and personalized medicine. This also provides additional data for the overall understanding of the role of fibrillin-1 in various organs.

          Related collections

          Most cited references41

          • Record: found
          • Abstract: found
          • Article: not found

          Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

          The American College of Medical Genetics and Genomics (ACMG) previously developed guidance for the interpretation of sequence variants. 1 In the past decade, sequencing technology has evolved rapidly with the advent of high-throughput next generation sequencing. By adopting and leveraging next generation sequencing, clinical laboratories are now performing an ever increasing catalogue of genetic testing spanning genotyping, single genes, gene panels, exomes, genomes, transcriptomes and epigenetic assays for genetic disorders. By virtue of increased complexity, this paradigm shift in genetic testing has been accompanied by new challenges in sequence interpretation. In this context, the ACMG convened a workgroup in 2013 comprised of representatives from the ACMG, the Association for Molecular Pathology (AMP) and the College of American Pathologists (CAP) to revisit and revise the standards and guidelines for the interpretation of sequence variants. The group consisted of clinical laboratory directors and clinicians. This report represents expert opinion of the workgroup with input from ACMG, AMP and CAP stakeholders. These recommendations primarily apply to the breadth of genetic tests used in clinical laboratories including genotyping, single genes, panels, exomes and genomes. This report recommends the use of specific standard terminology: ‘pathogenic’, ‘likely pathogenic’, ‘uncertain significance’, ‘likely benign’, and ‘benign’ to describe variants identified in Mendelian disorders. Moreover, this recommendation describes a process for classification of variants into these five categories based on criteria using typical types of variant evidence (e.g. population data, computational data, functional data, segregation data, etc.). Because of the increased complexity of analysis and interpretation of clinical genetic testing described in this report, the ACMG strongly recommends that clinical molecular genetic testing should be performed in a CLIA-approved laboratory with results interpreted by a board-certified clinical molecular geneticist or molecular genetic pathologist or equivalent.
            • Record: found
            • Abstract: not found
            • Article: not found

            2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC).

              • Record: found
              • Abstract: found
              • Article: not found

              The revised Ghent nosology for the Marfan syndrome.

              The diagnosis of Marfan syndrome (MFS) relies on defined clinical criteria (Ghent nosology), outlined by international expert opinion to facilitate accurate recognition of this genetic aneurysm syndrome and to improve patient management and counselling. These Ghent criteria, comprising a set of major and minor manifestations in different body systems, have proven to work well since with improving molecular techniques, confirmation of the diagnosis is possible in over 95% of patients. However, concerns with the current nosology are that some of the diagnostic criteria have not been sufficiently validated, are not applicable in children or necessitate expensive and specialised investigations. The recognition of variable clinical expression and the recently extended differential diagnosis further confound accurate diagnostic decision making. Moreover, the diagnosis of MFS--whether or not established correctly--can be stigmatising, hamper career aspirations, restrict life insurance opportunities, and cause psychosocial burden. An international expert panel has established a revised Ghent nosology, which puts more weight on the cardiovascular manifestations and in which aortic root aneurysm and ectopia lentis are the cardinal clinical features. In the absence of any family history, the presence of these two manifestations is sufficient for the unequivocal diagnosis of MFS. In absence of either of these two, the presence of a bonafide FBN1 mutation or a combination of systemic manifestations is required. For the latter a new scoring system has been designed. In this revised nosology, FBN1 testing, although not mandatory, has greater weight in the diagnostic assessment. Special considerations are given to the diagnosis of MFS in children and alternative diagnoses in adults. We anticipate that these new guidelines may delay a definitive diagnosis of MFS but will decrease the risk of premature or misdiagnosis and facilitate worldwide discussion of risk and follow-up/management guidelines.

                Author and article information

                Contributors
                guillaume.jondeau@aphp.fr
                Journal
                Genet Med
                Genet Med
                Genetics in Medicine
                Nature Publishing Group US (New York )
                1098-3600
                1530-0366
                17 March 2021
                17 March 2021
                2021
                : 23
                : 7
                : 1296-1304
                Affiliations
                [1 ]Université de Paris, LVTS, INSERM U1148, Hôpital Bichat-Claude-Bernard, Paris, France
                [2 ]GRID grid.411119.d, ISNI 0000 0000 8588 831X, Centre National de Reference pour le Syndrome de Marfan et les Syndromes Apparentés, VASCERN HTAD European Reference Centre, AP-HP, Hôpital Bichat-Claude-Bernard, ; Paris, France
                [3 ]GRID grid.411119.d, ISNI 0000 0000 8588 831X, Département de Génétique, AP-HP, Hôpital Bichat-Claude-Bernard, ; Paris, France
                [4 ]GRID grid.411119.d, ISNI 0000 0000 8588 831X, Service de Cardiologie, AP-HP, Hôpital Bichat-Claude-Bernard, ; Paris, France
                [5 ]GRID grid.411439.a, ISNI 0000 0001 2150 9058, Unité de Recherche Clinique, AP-HP, Hôpital Pitié- Salpêtrière, ; Paris, France
                [6 ]GRID grid.411119.d, ISNI 0000 0000 8588 831X, Service d’explorations fonctionnelles, AP-HP, Hôpital Bichat-Claude-Bernard, ; Paris, France
                Author information
                http://orcid.org/0000-0002-0101-2076
                Article
                1132
                10.1038/s41436-021-01132-x
                8257477
                33731877
                d820ea07-587e-471e-8676-b8d5c434741d
                © The Author(s) 2021

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 19 October 2020
                : 11 February 2021
                : 16 February 2021
                Funding
                Funded by: FundRef https://doi.org/10.13039/, Foundation Coeur-Recherche;
                Funded by: FundRef https://doi.org/10.13039/http://dx.doi.org/10.13039/501100003100, Fédération Française de Cardiologie;
                Funded by: FundRef https://doi.org/10.13039/http://dx.doi.org/10.13039/501100001665, Agence Nationale de la Recherche;
                Award ID: ANR-14-CE15-0012
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/http://dx.doi.org/10.13039/501100002738, Assistance Publique - Hôpitaux de Paris;
                Award ID: CRCBD18119
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/http://dx.doi.org/10.13039/100007354, Fondation Lefoulon Delalande;
                Categories
                Article
                Custom metadata
                © American College of Medical Genetics and Genomics 2021

                Genetics
                Genetics

                Comments

                Comment on this article

                Related Documents Log